Sayaka Fukuda

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Tomohiro Yoshida, Fumihiko Akahoshi, Hiroshi Sakashita et al. · Bioorganic & Medicinal Chemistry · 2012 · 148 citations · Full text

Biochemistry, Medicine, Rational Drug Design +7

Mitochondrial DNA Mutations Regulate Metastasis of Human Breast Cancer Cells

Hirotake Imanishi, Keisuke Hattori, Reiko Wada et al. · PLoS ONE · 2011 · 110 citations · Full text

Breast Oncology, Mitochondrial Biology, Reactive Oxygen Species +19

Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn’s Disease in the Japanese Population

Kayoko Sato, Mizuho Shiota, Sayaka Fukuda et al. · Journal of Clinical Immunology · 2009 · 73 citations · Full text

Enhanced glycolysis induced by mtDNA mutations does not regulate metastasis

Kaori Ishikawa, Osamu Hashizume, Nobuko Koshikawa et al. · FEBS Letters · 2008 · 43 citations

MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice

Takuma Tsuchida, Sayaka Fukuda, Hisanori Aoyama et al. · Lipids in Health and Disease · 2012 · 42 citations · Full text